Last reviewed · How we verify
NCT04478552
Analgesic Effect of Fascia Iliaca Compartment Block in Geriatric Patients With Hip Fracture
NA trial testing Fascia iliaca compartment block in Hip Fractures in 80 participants. Completed in 14 October 2021.
14 September 2021
Quick facts
| Lead sponsor | United Christian Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 June 2019 |
| Primary completion | 14 September 2021 |
| Estimated completion | 14 October 2021 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- Fascia iliaca compartment block — full drug profile →
- Placebo injection
Conditions studied
- Hip Fractures — all drugs for Hip Fractures →
Sponsor
United Christian Hospital
Who can join
65 and older, any sex, with Hip Fractures. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
As population in Hong Kong is aging, incidence of geriatrics hip fractures rises. Operative treatment for selective patients offers pain control, early mobilization and reduction in medical morbidities and mortalities. Research has shown that the pain from hip fracture left untreated may have significant physical and psychological effects on the patient, precipitating delirium, especially in elderly patients with hip fractures, and may delay operative management and may complicate hospital stay. Studies report that the pain management for limb fractures in the elderly is hugely sub-optimal with some suggesting that only 2% receive adequate analgesia. Adequate analgesia before definitive treatment of hip fracture may improve mobilization and cognitive performance. As a part of multi-modal pain management, Fascia iliaca compartment block is being increasingly popular as a simple, safe and effective regional technique for patients with hip fractures and proximal femoral shaft fractures, providing consistent analgesic effect for hip fracture patients, irrespective of the performing doctor's experience. This study aims to provide high level local evidence of the effect and efficacy of the fascia iliaca compartment block in preoperative pain control for patients with hip fracture admitted to Orthopaedic and Traumatology ward in United Christian Hospital.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04478552
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Fascia iliaca compartment block
Trials testing the same drug.
- NCT06210503 — PENG Block in Comparison With FICB for Hip Reconstruction in Children · NA · active not recruiting
- NCT05154318 — Efficacy of Pericapsular Nerve Group Block · NA · unknown
- NCT04210700 — Comparing Fascia Iliaca Compartment Block and Pericapsular Nerve Group Block for Hip Fracture Pain Control · NA · completed
- NCT04690647 — The Efficacy of Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Elective Total Hip Replacement. · NA · completed
- NCT03375112 — Fascia Iliaca Blocks for Pain Control After Total Hip Arthroplasty · Phase 4 · completed
Other recruiting trials for Hip Fractures
Currently open trials in the same condition.
- NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
- NCT07002723 — Effects of Esketamine Combined With Dexmedetomidine on Postoperative Sleep Quality · NA · recruiting
- NCT06893406 — Cervical Myelopathy in Hip Fracture Patients · NA · recruiting
- NCT06565910 — Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG) · Phase 4 · recruiting
- NCT06455813 — What Laxative Should be Used After Hip Fracture Surgery? · Phase 4 · recruiting
Other United Christian Hospital trials
Trials by the same sponsor.
- NCT07383467 — No Time to Wait: Single Session Intervention · NA · recruiting
- NCT04321447 — Clinical Practice Guideline for Neonatal Extravasation Injury · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04478552 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by United Christian Hospital
- Last refreshed: 23 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04478552.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing